Program death-1 and program death-1 ligands (PD1/PD-L1), which have been proven to play a major role in suppressing immune response, were found to be elevated expressed on T cells of patients with SLE [17, 18]. This evidence concerns the gene CD274 and systemic lupus erythematosus.